AbbVie’s big acquisition blowup: A one-off or an omen?


AbbVie swung the axe a year before it is expected to move into nearly a half-million square feet as the cornerstone tenant in BioMed Realty's Gateway of Pacific project in South San Francisco. One thing is sure: Corporate decisions sometimes can be as capricious as science.

Previous Kaleida, WNY Urology plans $5M surgery center
Next OHA is making progress in detecting improper Medicaid payments, new audit finds